THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,115,456 | -3.9% | 1,983,251 | +15.3% | 1.57% | +0.8% |
| Q2 2023 | $17,809,773 | -13.6% | 1,720,751 | -9.4% | 1.56% | -15.3% |
| Q1 2023 | $20,617,203 | -4.3% | 1,900,203 | -1.0% | 1.84% | -12.6% |
| Q4 2022 | $21,546,035 | +10.7% | 1,920,324 | +0.1% | 2.11% | +52.9% |
| Q3 2022 | $19,462,000 | -32.3% | 1,919,354 | -39.5% | 1.38% | -15.3% |
| Q2 2022 | $28,750,000 | +784.6% | 3,173,254 | +833.3% | 1.63% | +1338.9% |
| Q1 2022 | $3,250,000 | – | 340,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |